Literature DB >> 18211621

Neutropenia, thrombocytopenia and hepatic injury associated with dexketoprofen trometamol therapy in a previously healthy 35-year-old woman.

S Zabala1, M J Calpe, G Pérez, F J Lerín, L Mouronval.   

Abstract

This case report describes a previously healthy 35-year-old woman, with an episode of fever, neutropenia, thrombocytopenia and elevation of biochemical markers of liver injury, 10 days after beginning drug therapy with dexketoprofen trometamol. Infectious and autoimmune causes of neutropenia, and viral or autoimmune hepatitis were excluded. The resolution following withdrawal of dexketoprofen trometamol confirms the possibility of an adverse drug reaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18211621     DOI: 10.1111/j.1365-2710.2008.00881.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  5 in total

1.  Esophagitis due to dexketoprofen trometamol: a rare case report.

Authors:  Sehmus Olmez; Salim Donmez; Mehmet Aslan; Sevdegul Karadas; Alpaslan Yavuz
Journal:  Wien Klin Wochenschr       Date:  2014-11-21       Impact factor: 1.704

Review 2.  Practical guidelines for diagnosis and early management of drug-induced liver injury.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

3.  Effect of low-dose dexketoprofen trometamol and paracetamol on postoperative complications after impacted third molar surgery on healthy volunteers: A pilot study.

Authors:  Cennet-Neslihan Eroglu; Ercan Durmus; Demet Kiresi
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-11-01

4.  Anaphylaxis after intravenous infusion of dexketoprofen trometamol.

Authors:  Sertac Guler; Ilyas Ertok; Nurdan Yilmaz Sahin; Hayri Ramadan; Yavuz Katirci
Journal:  Turk J Emerg Med       Date:  2016-09-29

Review 5.  Oxytocin and cardioprotection in diabetes and obesity.

Authors:  Marek Jankowski; Tom L Broderick; Jolanta Gutkowska
Journal:  BMC Endocr Disord       Date:  2016-06-07       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.